Influence of rejection on late graft function after heart transplantation.
Livi
U
U
Department of Cardiovascular Surgery, University of Padova Medical School, Italy.
Milano
A
A
Caforio
A L
AL
Grassi
G
G
Feltrin
G
G
Boffa
G M
GM
D'Agnolo
A
A
Angelini
A
A
Thiene
G
G
Casarotto
D
D
D000293:Adolescent; D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000627:therapeutic use; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use; D001707:Biopsy, Needle; D002648:Child; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology / Q000503:physiopathology*; D016027:Heart Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine